Leptin (116-130), amide, mouse: Precision Tool for Metabolic and Inflammatory Pathway Dissection

Principle and Setup: Targeting Energy Homeostasis and Beyond

Leptin (116-130), amide, mouse, is a potent peptide fragment derived from the adipocyte-derived hormone leptin, encompassing the Ser-Cys-Ser-Leu-Pro-Gln-Thr-Ser-Gly-Leu-Gln-Lys-Pro-Glu-Ser-NH2 sequence. This fragment faithfully recapitulates core functional properties of native leptin, modulating food intake, energy homeostasis, and body weight in murine models (source: Defined Peptide for Obesity Research). Beyond its canonical roles, leptin is increasingly recognized for pleiotropic effects spanning hematopoiesis, angiogenesis, immune modulation, and cardiovascular regulation.

APExBIO supplies Leptin (116-130), amide, mouse, as a solid peptide optimized for experimental reproducibility. The peptide’s high solubility in DMSO (≥156 mg/mL) and water (≥24.15 mg/mL) enables flexible protocol design for both in vitro and in vivo applications (source: APExBIO product page).

Step-by-Step Workflow: Enhanced Protocols for Reliable Outcomes

Successful deployment of Leptin (116-130), amide, mouse in energy homeostasis studies or leptin signaling pathway assays demands meticulous attention to peptide preparation, dosing, and storage. The following workflow recommendations synthesize published best practices and hands-on optimizations (source: Applied Protocols & Optimization):

Protocol Parameters

• Peptide Reconstitution | 2 mg/mL in sterile water or DMSO | All in vitro and in vivo assays | Ensures complete solubilization and prevents aggregation for consistent dosing | product_spec
• Storage Conditions | -20°C, desiccated | Long-term stock storage | Maintains peptide stability and bioactivity; repeated freeze-thaw cycles should be avoided | product_spec
• Working Solution Use | Use within 8 hours of reconstitution | Cell-based, tissue, or animal models | Minimizes degradation and preserves biological effect, as prolonged storage at room temperature reduces peptide potency | workflow_recommendation
• In Vivo Dosage | 100–500 μg/kg body weight, i.p. injection | Murine models of obesity or diabetes | Doses within this range have demonstrated robust effects on food intake and metabolic endpoints | product_spec
• In Vitro Concentration | 10–100 nM final | Cellular assays probing leptin signaling | Enables dose-response analysis and mapping of downstream effectors | workflow_recommendation

Advanced Applications and Comparative Advantages

Leptin (116-130), amide, mouse, stands out as a versatile tool for dissecting the leptin signaling pathway in metabolic, immunological, and cardiovascular research. Unlike full-length leptin—which may introduce confounding structural or stability issues—this defined fragment allows precise control over experimental variables and is highly amenable to both acute and chronic exposure paradigms (source: Precision Tools for Metabolic Research).

Recent studies have leveraged this peptide to:

• Model leptin resistance and deficiency in murine obesity and diabetes research, enabling reproducible evaluation of therapeutic interventions (source: Defined Peptide for Obesity Research).
• Probe immune cell activation and T lymphocyte function, extending the use-case beyond metabolism into immunometabolism and inflammatory disease (source: New Horizons in Metabolic Signaling).
• Integrate with cardiovascular models to explore cross-talk between metabolic and inflammatory signaling, an emerging theme highlighted in the context of NLRP3 inflammasome studies (see below).

Compared to alternative leptin fragments, Leptin (116-130), amide, mouse, offers superior solubility and batch-to-batch consistency, minimizing the risk of assay drift and enabling cross-laboratory reproducibility (source: APExBIO product page).

Key Innovation from the Reference Study

The landmark study by Zhou et al. (source: Berberine Protects Against AF via SIRT6-AMPK–NLRP3 Inflammasome Axis) demonstrated that berberine, by upregulating the SIRT6-AMPK pathway, suppresses NLRP3 inflammasome activation, thereby preventing angiotensin II-induced atrial fibrosis and reducing vulnerability to atrial fibrillation. This work underscores the mechanistic interplay between metabolic regulators and inflammatory signaling in cardiovascular disease.

Translational Takeaway for Leptin (116-130), amide, mouse Users: Given leptin’s capacity to modulate inflammation, oxidative stress, and immune cell recruitment, researchers can adopt similar pathway-centric workflows—such as targeted gene/protein expression profiling, inflammasome activation assays, and AMPK activity monitoring—to interrogate the impact of leptin fragments on metabolic and cardiovascular endpoints in cell or murine models. Such designs can reveal how leptin deficiency or resistance alters susceptibility to inflammatory or fibrotic sequelae, paralleling the SIRT6-AMPK axis explored in the berberine study.

Troubleshooting and Optimization Tips

Maximizing the reliability and interpretability of experiments involving Leptin (116-130), amide, mouse, requires proactive troubleshooting:

• Solubility Failures: If undissolved peptide persists, switch to DMSO as the solvent (up to ≥156 mg/mL) and vortex gently. Avoid high ethanol concentrations, as the peptide is insoluble in ethanol (source: APExBIO product page).
• Loss of Bioactivity: Prepare fresh working solutions for each experiment and limit exposure to room temperature to under 8 hours. Test peptide integrity using analytical HPLC if activity loss is suspected (source: workflow_recommendation).
• Variable In Vivo Responses: Standardize injection timing, vehicle composition, and animal fasting state to reduce variability in food intake or metabolic readouts (source: Applied Protocols & Optimization).
• Assay Drift: Use validated internal standards and, where possible, parallel full-length leptin controls to benchmark the activity of the 116–130 fragment (source: workflow_recommendation).

Cross-Reference: Complementary and Extending Content

• Applied Protocols & Optimization: Provides detailed hands-on assay protocols and troubleshooting strategies that expand on the workflow recommendations in this article, serving as a practical extension.
• New Horizons in Metabolic Signaling: Offers mechanistic insights into leptin’s roles beyond metabolism, complementing this article’s focus on advanced use-cases and cross-domain applications.
• Precision Tools for Metabolic Research: Emphasizes the peptide’s solubility and batch consistency, directly supporting the comparative advantages detailed above.

Together, these resources enable a comprehensive, multi-angle approach to leveraging Leptin (116-130), amide, mouse, in cutting-edge research.

Why this cross-domain matters, maturity, and limitations

The intersection of metabolic and inflammatory signaling is now recognized as a key driver of disease pathogenesis, as illustrated by the reference study’s focus on the SIRT6-AMPK-NLRP3 axis in cardiac remodeling. Applying Leptin (116-130), amide, mouse, to similar workflows can uncover novel connections between energy homeostasis regulation and immune/inflammatory mechanisms. However, most current data derive from murine and cellular models; translation to human systems or clinical endpoints remains at an early stage, and careful cross-validation is essential (source: Berberine Protects Against AF via SIRT6-AMPK–NLRP3 Inflammasome Axis).

Future Outlook: Implications for Metabolic and Inflammatory Disease Modeling

Ongoing advances in metabolic research increasingly leverage defined hormone fragments like Leptin (116-130), amide, mouse, to unravel disease mechanisms with high precision. As demonstrated by the integration of pathway-centric approaches (e.g., SIRT6-AMPK-NLRP3), future studies will likely combine metabolic, immune, and tissue remodeling endpoints to generate holistic models of disease progression and therapeutic response. The robust performance and reproducibility of APExBIO’s peptide ensure it will remain at the forefront of these translational efforts, supporting both fundamental discovery and preclinical validation (source: workflow_recommendation).

For more information or to order Leptin (116-130), amide, mouse, visit APExBIO’s official product page.